AU Stock MarketDetailed Quotes
PARO Paradigm Biopharmaceuticals Ltd
- 0.006
- -0.003-33.33%
20min DelayMarket Closed Sep 27 11:30 AET
2.10MMarket Cap0.00P/E (Static)
0.006High0.006Low20.15KVolume0.006Open0.009Pre Close121.00Turnover0.10052wk High0.01%Turnover Ratio350.36MShares0.00552wk Low--EPS TTM1.88MFloat Cap0.100Historical High0.00P/E (Static)314.05MShs Float0.005Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Paradigm Biopharmaceuticals Ltd Company
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulphate sodium (iPPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The company has registered the trademarks Zilosul and Rhinosul for the commercialization of iPPS.
Company Profile
SymbolPARO
Company NameParadigm Biopharmaceuticals Ltd
Founded2014
MarketASX
Employees50
Fiscal Year Ends06-30
Address500 Collins Street Level 15
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 396295566
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
Company Executives
- Name
- Position
- Salary
- Dr. Donna Skerrett
- Director and Chief Medical Officer
- --
- Paul Rennie
- Executive Chairman of the Board and Managing Director
- --
- Helen Fisher, B.Sc. ,L.L.B.,L.L.M.
- Director
- --
- John Gaffney
- Director
- --
- Amos Meltzer
- Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data